Free Trial

Illumina (ILMN) Stock Price, News & Analysis

Illumina logo
$99.27 +2.12 (+2.18%)
Closing price 07/8/2025 04:00 PM Eastern
Extended Trading
$95.90 -3.36 (-3.39%)
As of 06:52 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Illumina Stock (NASDAQ:ILMN)

Key Stats

Today's Range
$97.04
$100.25
50-Day Range
$74.53
$100.44
52-Week Range
$68.70
$156.66
Volume
1.89 million shs
Average Volume
2.14 million shs
Market Capitalization
$15.71 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$127.42
Consensus Rating
Moderate Buy

Company Overview

Illumina Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
97th Percentile Overall Score

ILMN MarketRank™: 

Illumina scored higher than 97% of companies evaluated by MarketBeat, and ranked 42nd out of 922 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Illumina has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 9 buy ratings, 9 hold ratings, and 1 sell rating.

  • Amount of Analyst Coverage

    Illumina has been the subject of 8 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Illumina's stock forecast and price target.
  • Earnings Growth

    Earnings for Illumina are expected to grow by 14.41% in the coming year, from $4.51 to $5.16 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Illumina is -16.35, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Illumina is -16.35, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Growth Ratio

    Illumina has a PEG Ratio of 1.91. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Illumina has a P/B Ratio of 6.64. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Illumina's valuation and earnings.
  • Percentage of Shares Shorted

    4.09% of the float of Illumina has been sold short.
  • Short Interest Ratio / Days to Cover

    Illumina has a short interest ratio ("days to cover") of 2.8, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Illumina has recently increased by 14.96%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Illumina does not currently pay a dividend.

  • Dividend Growth

    Illumina does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    4.09% of the float of Illumina has been sold short.
  • Short Interest Ratio / Days to Cover

    Illumina has a short interest ratio ("days to cover") of 2.8, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Illumina has recently increased by 14.96%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Illumina has a news sentiment score of 1.56. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.57 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 17 news articles for Illumina this week, compared to 18 articles on an average week.
  • Search Interest

    Only 16 people have searched for ILMN on MarketBeat in the last 30 days. This is a decrease of -20% compared to the previous 30 days.
  • MarketBeat Follows

    6 people have added Illumina to their MarketBeat watchlist in the last 30 days. This is an increase of 50% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Illumina insiders have bought more of their company's stock than they have sold. Specifically, they have bought $495,381.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    Only 0.17% of the stock of Illumina is held by insiders.

  • Percentage Held by Institutions

    89.42% of the stock of Illumina is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Illumina's insider trading history.
Receive ILMN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Illumina and its competitors with MarketBeat's FREE daily newsletter.

ILMN Stock News Headlines

A new rule goes live in July — and the banks are quietly cashing in
A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.
Illumina, Inc. (ILMN): A Bull Case Theory
See More Headlines

ILMN Stock Analysis - Frequently Asked Questions

Illumina's stock was trading at $133.63 on January 1st, 2025. Since then, ILMN stock has decreased by 25.7% and is now trading at $99.27.

Illumina, Inc. (NASDAQ:ILMN) released its quarterly earnings data on Thursday, May, 8th. The life sciences company reported $0.97 EPS for the quarter, topping analysts' consensus estimates of $0.96 by $0.01. The firm's revenue was down 1.4% compared to the same quarter last year.
Read the conference call transcript
.

The following companies are subsidiaries of Illumina: Grail, Enancio, BlueBee, Edico Genome, Conexio Genomics, GenoLogics, NextBio, and more.

Top institutional investors of Illumina include Douglas Lane & Associates LLC (0.18%), Partnership Wealth Management LLC (0.01%), Kera Capital Partners Inc. and OMNI 360 Wealth Inc.. Insiders that own company stock include Susan H Tousi, Jacob Thaysen, Aimee L Hoyt and Alexander Aravanis.
View institutional ownership trends
.

Shares of ILMN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Illumina investors own include NVIDIA (NVDA), Meta Platforms (META), Tesla (TSLA), Advanced Micro Devices (AMD), Netflix (NFLX), Visa (V) and Alphabet (GOOG).

Company Calendar

Last Earnings
5/08/2025
Today
7/09/2025
Next Earnings (Estimated)
8/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Life Sciences Tools & Services
Current Symbol
NASDAQ:ILMN
CIK
1110803
Employees
9,030
Year Founded
1998

Price Target and Rating

High Price Target
$200.00
Low Price Target
$85.00
Potential Upside/Downside
+28.4%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
20 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
22.01
P/E Growth
1.91
Net Income
-$1.22 billion
Pretax Margin
-20.48%

Debt

Sales & Book Value

Annual Sales
$4.37 billion
Cash Flow
$4.79 per share
Price / Cash Flow
20.71
Book Value
$14.96 per share
Price / Book
6.64

Miscellaneous

Free Float
158,031,000
Market Cap
$15.71 billion
Optionable
Optionable
Beta
1.36

Social Links

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

This page (NASDAQ:ILMN) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners